Canakinumab in the routinary clinical practice in cryopyrin-associated periodic syndromes (CAPS): one year of follow-up
Saved in:
Main Authors: | Martini A (Author), Finetti M (Author), Stabile A (Author), Alessio M (Author), Zulian F (Author), Lepore L (Author), Caorsi R (Author), Gattorno M (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2011-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
National CAPS (Cryopyrin-Associated Periodic Syndrome) Registry
by: Gallizzi R, et al.
Published: (2011) -
Dosing patterns of canakinumab in patients with Cryopyrin-Associated Periodic Syndromes (CAPS): A comparative analysis of a study in Western versus Japanese patients
by: Takada H, et al.
Published: (2011) -
CRYOPYRIN ASSOCIATED PERIODIC SYNDROME
by: M. Gattorno
Published: (2013) -
Effectiveness and safety of canakinumab in cryopyrin-associated periodic syndrome: a retrospective study in China
by: Xiaona Zhu, et al.
Published: (2024) -
A refractory heterogeneous Cryopyrin-Associated Periodic Syndrome (CAPS) phenotype related to <it>V198M</it> mutation responds to canakinumab - a case report
by: Kuemmerle-Deschner Jasmin B, et al.
Published: (2011)